

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.31745363 |
| 2 | locomotory exploration behavior (GO:0035641) | 6.15415365 |
| 3 | NADH metabolic process (GO:0006734) | 5.85684439 |
| 4 | sodium ion export (GO:0071436) | 5.84013360 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.09317299 |
| 6 | cellular potassium ion homeostasis (GO:0030007) | 4.95458880 |
| 7 | layer formation in cerebral cortex (GO:0021819) | 4.90284566 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.83219124 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.71476394 |
| 10 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.71125412 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.69750049 |
| 12 | regulation of synapse structural plasticity (GO:0051823) | 4.55146728 |
| 13 | proline biosynthetic process (GO:0006561) | 4.41165674 |
| 14 | cell communication by electrical coupling (GO:0010644) | 4.29314197 |
| 15 | glutamate secretion (GO:0014047) | 4.24340493 |
| 16 | activation of protein kinase A activity (GO:0034199) | 4.21855599 |
| 17 | oxaloacetate metabolic process (GO:0006107) | 4.20899801 |
| 18 | Golgi transport vesicle coating (GO:0048200) | 4.13802084 |
| 19 | COPI coating of Golgi vesicle (GO:0048205) | 4.13802084 |
| 20 | potassium ion import (GO:0010107) | 4.09224596 |
| 21 | vocalization behavior (GO:0071625) | 4.01089294 |
| 22 | exploration behavior (GO:0035640) | 3.96653290 |
| 23 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.90415447 |
| 24 | neurotransmitter secretion (GO:0007269) | 3.85331071 |
| 25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.84980551 |
| 26 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.83581206 |
| 27 | cellular sodium ion homeostasis (GO:0006883) | 3.81595010 |
| 28 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.80343785 |
| 29 | establishment of nucleus localization (GO:0040023) | 3.73942268 |
| 30 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.70467001 |
| 31 | synaptic vesicle exocytosis (GO:0016079) | 3.70328778 |
| 32 | proline metabolic process (GO:0006560) | 3.68939207 |
| 33 | cell communication involved in cardiac conduction (GO:0086065) | 3.66791184 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.63760167 |
| 35 | proline transport (GO:0015824) | 3.60765354 |
| 36 | regulation of ARF protein signal transduction (GO:0032012) | 3.60330542 |
| 37 | vitamin transmembrane transport (GO:0035461) | 3.59223196 |
| 38 | neuromuscular process controlling balance (GO:0050885) | 3.58308277 |
| 39 | glycine transport (GO:0015816) | 3.51990023 |
| 40 | regulation of mitotic spindle organization (GO:0060236) | 3.51523115 |
| 41 | dendritic spine morphogenesis (GO:0060997) | 3.50257214 |
| 42 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.40386709 |
| 43 | regulation of synaptic vesicle transport (GO:1902803) | 3.39428548 |
| 44 | gamma-aminobutyric acid transport (GO:0015812) | 3.39168117 |
| 45 | lysine metabolic process (GO:0006553) | 3.33807270 |
| 46 | lysine catabolic process (GO:0006554) | 3.33807270 |
| 47 | potassium ion homeostasis (GO:0055075) | 3.32732428 |
| 48 | gluconeogenesis (GO:0006094) | 3.31170820 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.30432161 |
| 50 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.29259141 |
| 51 | creatine metabolic process (GO:0006600) | 3.25947543 |
| 52 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.25770213 |
| 53 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.24787865 |
| 54 | peptidyl-lysine dimethylation (GO:0018027) | 3.22397429 |
| 55 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.20006510 |
| 56 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.19666807 |
| 57 | prepulse inhibition (GO:0060134) | 3.19436820 |
| 58 | protein retention in ER lumen (GO:0006621) | 3.17983995 |
| 59 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.16685035 |
| 60 | maternal placenta development (GO:0001893) | 3.16048504 |
| 61 | neuronal action potential propagation (GO:0019227) | 3.14856060 |
| 62 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.14093360 |
| 63 | tricarboxylic acid cycle (GO:0006099) | 3.09708801 |
| 64 | cell volume homeostasis (GO:0006884) | 3.09037926 |
| 65 | hexose biosynthetic process (GO:0019319) | 3.07467936 |
| 66 | fructose metabolic process (GO:0006000) | 3.07136228 |
| 67 | long-term memory (GO:0007616) | 3.05879355 |
| 68 | positive regulation of membrane potential (GO:0045838) | 3.00884730 |
| 69 | membrane repolarization (GO:0086009) | 3.00293850 |
| 70 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00249248 |
| 71 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.00227419 |
| 72 | negative regulation of mRNA processing (GO:0050686) | 2.99936724 |
| 73 | plasma membrane repair (GO:0001778) | 2.96683724 |
| 74 | hyperosmotic salinity response (GO:0042538) | 2.96429894 |
| 75 | monosaccharide biosynthetic process (GO:0046364) | 2.96054494 |
| 76 | desmosome organization (GO:0002934) | 2.94963649 |
| 77 | amino acid import (GO:0043090) | 2.94903106 |
| 78 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.90451744 |
| 79 | carnitine shuttle (GO:0006853) | 2.88744606 |
| 80 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.87171386 |
| 81 | clathrin coat assembly (GO:0048268) | 2.86304639 |
| 82 | adenine nucleotide transport (GO:0051503) | 2.86013710 |
| 83 | cellular hyperosmotic response (GO:0071474) | 2.85915374 |
| 84 | tricarboxylic acid metabolic process (GO:0072350) | 2.85544504 |
| 85 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.84189704 |
| 86 | neurotransmitter transport (GO:0006836) | 2.83990199 |
| 87 | positive regulation of synapse maturation (GO:0090129) | 2.83186542 |
| 88 | vesicle transport along microtubule (GO:0047496) | 2.82177374 |
| 89 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.82153988 |
| 90 | activation of Rac GTPase activity (GO:0032863) | 2.82027403 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.81219733 |
| 92 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.80827638 |
| 93 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.78726984 |
| 94 | auditory behavior (GO:0031223) | 2.77874557 |
| 95 | adherens junction assembly (GO:0034333) | 2.77591432 |
| 96 | negative regulation of sodium ion transport (GO:0010766) | 2.77469094 |
| 97 | phosphate ion transmembrane transport (GO:0035435) | 2.77139810 |
| 98 | negative regulation of cell size (GO:0045792) | 2.77114500 |
| 99 | regulation of ARF GTPase activity (GO:0032312) | 2.76939847 |
| 100 | alanine transport (GO:0032328) | 2.76869881 |
| 101 | DNA unwinding involved in DNA replication (GO:0006268) | 2.76622841 |
| 102 | phosphate ion transport (GO:0006817) | 2.75462613 |
| 103 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.75393921 |
| 104 | neuromuscular process controlling posture (GO:0050884) | 2.75101986 |
| 105 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.74830642 |
| 106 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.74750050 |
| 107 | protein localization to synapse (GO:0035418) | 2.73857565 |
| 108 | aspartate family amino acid catabolic process (GO:0009068) | 2.72860132 |
| 109 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.71632168 |
| 110 | glucose 6-phosphate metabolic process (GO:0051156) | 2.71627606 |
| 111 | regulation of cholesterol metabolic process (GO:0090181) | 2.71201884 |
| 112 | cAMP biosynthetic process (GO:0006171) | 2.70881330 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 2.70480411 |
| 114 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.69516747 |
| 115 | dendrite morphogenesis (GO:0048813) | 2.68875958 |
| 116 | carnitine transport (GO:0015879) | 2.67926480 |
| 117 | amino-acid betaine transport (GO:0015838) | 2.67926480 |
| 118 | regulation of early endosome to late endosome transport (GO:2000641) | 2.67459812 |
| 119 | glial cell proliferation (GO:0014009) | 2.67437945 |
| 120 | purine nucleotide transport (GO:0015865) | 2.67431748 |
| 121 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.67226321 |
| 122 | regulation of neurotransmitter levels (GO:0001505) | 2.66647474 |
| 123 | mitotic chromosome condensation (GO:0007076) | 2.66541262 |
| 124 | negative regulation of mRNA metabolic process (GO:1903312) | 2.64117366 |
| 125 | 2-oxoglutarate metabolic process (GO:0006103) | 2.64061993 |
| 126 | regulation of histone H3-K27 methylation (GO:0061085) | 2.63494500 |
| 127 | cardiac muscle contraction (GO:0060048) | 2.63305802 |
| 128 | L-amino acid import (GO:0043092) | 2.63058096 |
| 129 | succinate metabolic process (GO:0006105) | 2.62356071 |
| 130 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.60934680 |
| 131 | regulation of translational fidelity (GO:0006450) | 2.60745945 |
| 132 | membrane depolarization during action potential (GO:0086010) | 2.59973264 |
| 133 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.58915333 |
| 134 | carnitine transmembrane transport (GO:1902603) | 2.58780467 |
| 135 | regulation of bile acid biosynthetic process (GO:0070857) | 2.58158813 |
| 136 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.57803500 |
| 137 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.57481916 |
| 138 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.57481916 |
| 139 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.57252297 |
| 140 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.56478051 |
| 141 | regulation of synaptic plasticity (GO:0048167) | 2.56096742 |
| 142 | ethanol oxidation (GO:0006069) | 2.56081666 |
| 143 | regulation of synapse maturation (GO:0090128) | 2.55939768 |
| 144 | glycolytic process (GO:0006096) | 2.55531062 |
| 145 | cell-substrate adherens junction assembly (GO:0007045) | 2.52906279 |
| 146 | focal adhesion assembly (GO:0048041) | 2.52906279 |
| 147 | dendritic spine organization (GO:0097061) | 2.52048613 |
| 148 | lung epithelium development (GO:0060428) | 2.51942835 |
| 149 | regulation of transmembrane transporter activity (GO:0022898) | 2.50387247 |
| 150 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.50183614 |
| 151 | positive regulation of nuclease activity (GO:0032075) | 2.46408155 |
| 152 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.44001216 |
| 153 | regulation of spindle organization (GO:0090224) | 2.43970030 |
| 154 | regulation of protein dephosphorylation (GO:0035304) | 2.42900790 |
| 155 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.39558160 |
| 156 | ethanol metabolic process (GO:0006067) | 2.38700847 |
| 157 | urea cycle (GO:0000050) | 2.38626245 |
| 158 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.36775968 |
| 159 | cerebellar granule cell differentiation (GO:0021707) | 2.35152898 |
| 160 | stress granule assembly (GO:0034063) | 2.34712405 |
| 161 | fatty acid homeostasis (GO:0055089) | 2.31818091 |
| 162 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.29557172 |
| 163 | NADPH regeneration (GO:0006740) | 2.29057384 |
| 164 | cellular response to nitric oxide (GO:0071732) | 2.29035167 |
| 165 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.28212966 |
| 166 | mRNA polyadenylation (GO:0006378) | 2.27578669 |
| 167 | sodium ion homeostasis (GO:0055078) | 2.26879887 |
| 168 | neutral lipid catabolic process (GO:0046461) | 2.25130433 |
| 169 | acylglycerol catabolic process (GO:0046464) | 2.25130433 |
| 170 | actin filament depolymerization (GO:0030042) | 2.23216785 |
| 171 | positive regulation of protein dephosphorylation (GO:0035307) | 2.23053488 |
| 172 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.22690341 |
| 173 | protein complex localization (GO:0031503) | 2.22646185 |
| 174 | urea metabolic process (GO:0019627) | 2.21846934 |
| 175 | cellular protein complex localization (GO:0034629) | 2.21185870 |
| 176 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.20730260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.55931444 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.49420623 |
| 3 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.06027157 |
| 4 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.99661111 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.98713875 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.98070758 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.80167720 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.38283026 |
| 9 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.22775341 |
| 10 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.19146004 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18823599 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.18123503 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.15616895 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.12418399 |
| 15 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.11426707 |
| 16 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.04138009 |
| 17 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.97487294 |
| 18 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.94710800 |
| 19 | KDM2B_26808549_Chip-Seq_K562_Human | 1.94569717 |
| 20 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.91600410 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 1.89343617 |
| 22 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.86890791 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85926036 |
| 24 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.80919994 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.79144197 |
| 26 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.78514629 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78319339 |
| 28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.74954461 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74312685 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.73368534 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.73368534 |
| 32 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.72911647 |
| 33 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.71494695 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.69832067 |
| 35 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.69784665 |
| 36 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.68152860 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.68056986 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.67317231 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66200555 |
| 40 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.65628328 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64991102 |
| 42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64563605 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.62808546 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62739329 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.61884001 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60988094 |
| 47 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60794147 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.60630446 |
| 49 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57762418 |
| 50 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57071775 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52742929 |
| 52 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51877518 |
| 53 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.48704654 |
| 54 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47416723 |
| 55 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.46726923 |
| 56 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46096488 |
| 57 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.45751361 |
| 58 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43671743 |
| 59 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.43227964 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42526344 |
| 61 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42351314 |
| 62 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.41083976 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39516501 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.37693736 |
| 65 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.36145131 |
| 66 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.34757200 |
| 67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34188537 |
| 68 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.33958961 |
| 69 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32528996 |
| 70 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.31475259 |
| 71 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30708152 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29696973 |
| 73 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.28971103 |
| 74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27471813 |
| 75 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.26997258 |
| 76 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26877240 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26710397 |
| 78 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25808857 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25161770 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.24488634 |
| 81 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.23464222 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23100246 |
| 83 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.22531770 |
| 84 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.20362167 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20220081 |
| 86 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.20206034 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19174545 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18940869 |
| 89 | P68_20966046_ChIP-Seq_HELA_Human | 1.18865998 |
| 90 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.18265211 |
| 91 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.17931910 |
| 92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17429504 |
| 93 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17406987 |
| 94 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.16419510 |
| 95 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.15793268 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15365512 |
| 97 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.14229821 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13273767 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12983652 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12983652 |
| 101 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12894022 |
| 102 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12745885 |
| 103 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12500586 |
| 104 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12357270 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10866587 |
| 106 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.10230736 |
| 107 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09817079 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09767642 |
| 109 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09475804 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09469674 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09284567 |
| 112 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.08964493 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08390140 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08216083 |
| 115 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06838504 |
| 116 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.06561436 |
| 117 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06431245 |
| 118 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05976560 |
| 119 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.05661754 |
| 120 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.05138740 |
| 121 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05080640 |
| 122 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.05050591 |
| 123 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.04839980 |
| 124 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03858729 |
| 125 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03512303 |
| 126 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02659653 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02539064 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02090448 |
| 129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01928922 |
| 130 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.01597153 |
| 131 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01565480 |
| 132 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.00515672 |
| 133 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00073545 |
| 134 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.99650957 |
| 135 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99275788 |
| 136 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98496481 |
| 137 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98330902 |
| 138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98320616 |
| 139 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98120115 |
| 140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98049507 |
| 141 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97855314 |
| 142 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97555570 |
| 143 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97196551 |
| 144 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96627683 |
| 145 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.96373407 |
| 146 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96230672 |
| 147 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93826960 |
| 148 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.93772715 |
| 149 | AR_19668381_ChIP-Seq_PC3_Human | 0.91974065 |
| 150 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91131790 |
| 151 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.90299771 |
| 152 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89704833 |
| 153 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89636962 |
| 154 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89234074 |
| 155 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.89036161 |
| 156 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88710505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.68265140 |
| 2 | MP0002822_catalepsy | 3.49283560 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.39930544 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.37355034 |
| 5 | MP0004270_analgesia | 2.82070465 |
| 6 | MP0000566_synostosis | 2.64017878 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 2.48481393 |
| 8 | MP0004885_abnormal_endolymph | 2.46850251 |
| 9 | MP0004130_abnormal_muscle_cell | 2.46426117 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.42519005 |
| 11 | MP0008961_abnormal_basal_metabolism | 2.40032647 |
| 12 | MP0009745_abnormal_behavioral_response | 2.35732289 |
| 13 | MP0008569_lethality_at_weaning | 2.28495497 |
| 14 | MP0009672_abnormal_birth_weight | 2.22694854 |
| 15 | MP0005670_abnormal_white_adipose | 2.19901237 |
| 16 | MP0002909_abnormal_adrenal_gland | 2.11720077 |
| 17 | MP0005409_darkened_coat_color | 2.11316781 |
| 18 | MP0003329_amyloid_beta_deposits | 2.05616387 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.04457089 |
| 20 | MP0002064_seizures | 2.02318431 |
| 21 | MP0004084_abnormal_cardiac_muscle | 1.98616702 |
| 22 | MP0005423_abnormal_somatic_nervous | 1.96154924 |
| 23 | MP0003111_abnormal_nucleus_morphology | 1.94545313 |
| 24 | MP0004043_abnormal_pH_regulation | 1.93981424 |
| 25 | MP0004782_abnormal_surfactant_physiolog | 1.91881481 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 1.91231849 |
| 27 | MP0009046_muscle_twitch | 1.89670151 |
| 28 | MP0003123_paternal_imprinting | 1.88892592 |
| 29 | MP0003693_abnormal_embryo_hatching | 1.81982111 |
| 30 | MP0005451_abnormal_body_composition | 1.80992730 |
| 31 | MP0000678_abnormal_parathyroid_gland | 1.78601444 |
| 32 | MP0000747_muscle_weakness | 1.75088513 |
| 33 | MP0001730_embryonic_growth_arrest | 1.73375988 |
| 34 | * MP0004215_abnormal_myocardial_fiber | 1.73140159 |
| 35 | MP0002249_abnormal_larynx_morphology | 1.73009551 |
| 36 | MP0003879_abnormal_hair_cell | 1.72761231 |
| 37 | MP0001486_abnormal_startle_reflex | 1.69177549 |
| 38 | MP0004858_abnormal_nervous_system | 1.66365006 |
| 39 | MP0003880_abnormal_central_pattern | 1.63991460 |
| 40 | MP0005360_urolithiasis | 1.62181623 |
| 41 | MP0002272_abnormal_nervous_system | 1.62116686 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.60934215 |
| 43 | MP0002139_abnormal_hepatobiliary_system | 1.60104572 |
| 44 | MP0001346_abnormal_lacrimal_gland | 1.59849483 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.58901645 |
| 46 | MP0004036_abnormal_muscle_relaxation | 1.58359675 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.56134335 |
| 48 | MP0002796_impaired_skin_barrier | 1.55031801 |
| 49 | MP0003646_muscle_fatigue | 1.53006649 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.51631266 |
| 51 | MP0004811_abnormal_neuron_physiology | 1.49838502 |
| 52 | MP0005187_abnormal_penis_morphology | 1.47626526 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.47270366 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 1.46619371 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.43428584 |
| 56 | MP0005058_abnormal_lysosome_morphology | 1.43234824 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.42779016 |
| 58 | MP0004957_abnormal_blastocyst_morpholog | 1.42662587 |
| 59 | * MP0000751_myopathy | 1.41017084 |
| 60 | MP0002734_abnormal_mechanical_nocicepti | 1.37112007 |
| 61 | MP0003633_abnormal_nervous_system | 1.35963890 |
| 62 | MP0001501_abnormal_sleep_pattern | 1.32990501 |
| 63 | * MP0006036_abnormal_mitochondrial_physio | 1.32865021 |
| 64 | MP0003283_abnormal_digestive_organ | 1.31639094 |
| 65 | * MP0004087_abnormal_muscle_fiber | 1.28151828 |
| 66 | MP0003075_altered_response_to | 1.27448274 |
| 67 | MP0008872_abnormal_physiological_respon | 1.26496862 |
| 68 | MP0001968_abnormal_touch/_nociception | 1.26056765 |
| 69 | MP0005076_abnormal_cell_differentiation | 1.25883688 |
| 70 | MP0004145_abnormal_muscle_electrophysio | 1.25648791 |
| 71 | MP0004484_altered_response_of | 1.23491839 |
| 72 | MP0000579_abnormal_nail_morphology | 1.22062353 |
| 73 | MP0004147_increased_porphyrin_level | 1.21636894 |
| 74 | MP0005666_abnormal_adipose_tissue | 1.21629055 |
| 75 | MP0005365_abnormal_bile_salt | 1.21212297 |
| 76 | MP0005623_abnormal_meninges_morphology | 1.20744636 |
| 77 | MP0004233_abnormal_muscle_weight | 1.19777385 |
| 78 | MP0004924_abnormal_behavior | 1.15987821 |
| 79 | MP0005386_behavior/neurological_phenoty | 1.15987821 |
| 80 | MP0008260_abnormal_autophagy | 1.15686783 |
| 81 | MP0003566_abnormal_cell_adhesion | 1.15505818 |
| 82 | MP0000569_abnormal_digit_pigmentation | 1.14135046 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 1.12325557 |
| 84 | MP0001440_abnormal_grooming_behavior | 1.11579005 |
| 85 | MP0000350_abnormal_cell_proliferation | 1.07802751 |
| 86 | MP0001348_abnormal_lacrimal_gland | 1.05399079 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05021211 |
| 88 | MP0008874_decreased_physiological_sensi | 1.03938677 |
| 89 | MP0002080_prenatal_lethality | 1.02801762 |
| 90 | MP0001502_abnormal_circadian_rhythm | 1.02670204 |
| 91 | MP0002269_muscular_atrophy | 1.02656565 |
| 92 | MP0005620_abnormal_muscle_contractility | 1.02512228 |
| 93 | MP0002234_abnormal_pharynx_morphology | 1.02247444 |
| 94 | MP0003868_abnormal_feces_composition | 1.02031497 |
| 95 | MP0003690_abnormal_glial_cell | 1.01547187 |
| 96 | MP0002837_dystrophic_cardiac_calcinosis | 1.00582299 |
| 97 | MP0002970_abnormal_white_adipose | 1.00098354 |
| 98 | MP0004085_abnormal_heartbeat | 0.99305029 |
| 99 | MP0003878_abnormal_ear_physiology | 0.99242395 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.99242395 |
| 101 | MP0002067_abnormal_sensory_capabilities | 0.98903814 |
| 102 | MP0005501_abnormal_skin_physiology | 0.98612762 |
| 103 | MP0008932_abnormal_embryonic_tissue | 0.98438820 |
| 104 | MP0002066_abnormal_motor_capabilities/c | 0.98410077 |
| 105 | MP0002971_abnormal_brown_adipose | 0.97930460 |
| 106 | MP0003631_nervous_system_phenotype | 0.97380151 |
| 107 | MP0002557_abnormal_social/conspecific_i | 0.97160842 |
| 108 | MP0000955_abnormal_spinal_cord | 0.96673324 |
| 109 | MP0001672_abnormal_embryogenesis/_devel | 0.96453461 |
| 110 | MP0005380_embryogenesis_phenotype | 0.96453461 |
| 111 | MP0005535_abnormal_body_temperature | 0.95059347 |
| 112 | MP0006138_congestive_heart_failure | 0.94982750 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.93985635 |
| 114 | MP0002733_abnormal_thermal_nociception | 0.93674565 |
| 115 | * MP0010630_abnormal_cardiac_muscle | 0.92795187 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.92682609 |
| 117 | MP0005385_cardiovascular_system_phenoty | 0.91380643 |
| 118 | MP0001544_abnormal_cardiovascular_syste | 0.91380643 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.90709691 |
| 120 | MP0000462_abnormal_digestive_system | 0.87673391 |
| 121 | * MP0005330_cardiomyopathy | 0.87306737 |
| 122 | MP0004185_abnormal_adipocyte_glucose | 0.87110839 |
| 123 | MP0000604_amyloidosis | 0.86611715 |
| 124 | MP0002972_abnormal_cardiac_muscle | 0.86393361 |
| 125 | MP0003984_embryonic_growth_retardation | 0.85748654 |
| 126 | MP0000467_abnormal_esophagus_morphology | 0.84410585 |
| 127 | MP0001849_ear_inflammation | 0.84399500 |
| 128 | MP0009703_decreased_birth_body | 0.84035592 |
| 129 | MP0003077_abnormal_cell_cycle | 0.83440050 |
| 130 | MP0000013_abnormal_adipose_tissue | 0.82160068 |
| 131 | MP0010352_gastrointestinal_tract_polyps | 0.81762940 |
| 132 | MP0009840_abnormal_foam_cell | 0.80603485 |
| 133 | MP0002184_abnormal_innervation | 0.79864721 |
| 134 | MP0001970_abnormal_pain_threshold | 0.79809347 |
| 135 | MP0002088_abnormal_embryonic_growth/wei | 0.79378656 |
| 136 | MP0003122_maternal_imprinting | 0.79148335 |
| 137 | MP0001661_extended_life_span | 0.79136510 |
| 138 | MP0001697_abnormal_embryo_size | 0.78919754 |
| 139 | MP0002118_abnormal_lipid_homeostasis | 0.77704413 |
| 140 | MP0010329_abnormal_lipoprotein_level | 0.77662489 |
| 141 | MP0000537_abnormal_urethra_morphology | 0.76964576 |
| 142 | * MP0002106_abnormal_muscle_physiology | 0.76105692 |
| 143 | MP0002098_abnormal_vibrissa_morphology | 0.75862186 |
| 144 | MP0000003_abnormal_adipose_tissue | 0.75187507 |
| 145 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74556267 |
| 146 | MP0002152_abnormal_brain_morphology | 0.74193922 |
| 147 | MP0005332_abnormal_amino_acid | 0.72998486 |
| 148 | MP0005166_decreased_susceptibility_to | 0.72390126 |
| 149 | MP0001177_atelectasis | 0.72071995 |
| 150 | MP0002882_abnormal_neuron_morphology | 0.70854488 |
| 151 | MP0005621_abnormal_cell_physiology | 0.70574020 |
| 152 | MP0010678_abnormal_skin_adnexa | 0.69293762 |
| 153 | MP0000759_abnormal_skeletal_muscle | 0.69250989 |
| 154 | MP0002069_abnormal_eating/drinking_beha | 0.68968589 |
| 155 | MP0000920_abnormal_myelination | 0.68140322 |
| 156 | MP0009643_abnormal_urine_homeostasis | 0.67740785 |
| 157 | MP0000477_abnormal_intestine_morphology | 0.67394543 |
| 158 | MP0003115_abnormal_respiratory_system | 0.66955208 |
| 159 | MP0001881_abnormal_mammary_gland | 0.66207614 |
| 160 | MP0003183_abnormal_peptide_metabolism | 0.66128107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.80206506 |
| 2 | Visual hallucinations (HP:0002367) | 4.17844319 |
| 3 | Cholecystitis (HP:0001082) | 3.68088904 |
| 4 | Abnormal gallbladder physiology (HP:0012438) | 3.68088904 |
| 5 | Papilledema (HP:0001085) | 3.61028406 |
| 6 | Abnormality of glycolysis (HP:0004366) | 3.49599518 |
| 7 | Ventricular fibrillation (HP:0001663) | 3.37107086 |
| 8 | Bundle branch block (HP:0011710) | 3.34552288 |
| 9 | Focal motor seizures (HP:0011153) | 3.32359792 |
| 10 | Exercise-induced myalgia (HP:0003738) | 3.31413014 |
| 11 | Ankle clonus (HP:0011448) | 3.26149110 |
| 12 | Action tremor (HP:0002345) | 3.23359911 |
| 13 | Abnormality of the lower motor neuron (HP:0002366) | 3.22162515 |
| 14 | Abnormal social behavior (HP:0012433) | 3.21582539 |
| 15 | Impaired social interactions (HP:0000735) | 3.21582539 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.20786984 |
| 17 | Obstructive sleep apnea (HP:0002870) | 3.15327232 |
| 18 | Poor eye contact (HP:0000817) | 3.13135513 |
| 19 | Dysmetric saccades (HP:0000641) | 3.11795609 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 3.11723689 |
| 21 | Hyperacusis (HP:0010780) | 3.08807848 |
| 22 | Urinary urgency (HP:0000012) | 3.07285412 |
| 23 | Focal seizures (HP:0007359) | 3.05992653 |
| 24 | Insomnia (HP:0100785) | 2.95944923 |
| 25 | Postural instability (HP:0002172) | 2.95483528 |
| 26 | Depression (HP:0000716) | 2.93668701 |
| 27 | Deep venous thrombosis (HP:0002625) | 2.93608204 |
| 28 | Myoglobinuria (HP:0002913) | 2.77832440 |
| 29 | Increased serum pyruvate (HP:0003542) | 2.75027427 |
| 30 | Hemiplegia (HP:0002301) | 2.74173864 |
| 31 | Difficulty running (HP:0009046) | 2.73530031 |
| 32 | Elfin facies (HP:0004428) | 2.71255317 |
| 33 | Annular pancreas (HP:0001734) | 2.65418897 |
| 34 | Stridor (HP:0010307) | 2.62895089 |
| 35 | Increased nuchal translucency (HP:0010880) | 2.59510959 |
| 36 | Right ventricular cardiomyopathy (HP:0011663) | 2.57771936 |
| 37 | Pointed chin (HP:0000307) | 2.57253703 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.57012859 |
| 39 | Intention tremor (HP:0002080) | 2.55563288 |
| 40 | Resting tremor (HP:0002322) | 2.54146242 |
| 41 | Ankyloglossia (HP:0010296) | 2.52870348 |
| 42 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.50584708 |
| 43 | Myopathic facies (HP:0002058) | 2.49484645 |
| 44 | Macroorchidism (HP:0000053) | 2.49246587 |
| 45 | Bronchomalacia (HP:0002780) | 2.45365391 |
| 46 | Dysdiadochokinesis (HP:0002075) | 2.42857937 |
| 47 | Growth hormone excess (HP:0000845) | 2.41745616 |
| 48 | Atrioventricular block (HP:0001678) | 2.40941518 |
| 49 | Sudden death (HP:0001699) | 2.38391797 |
| 50 | Heart block (HP:0012722) | 2.32509658 |
| 51 | Increased circulating renin level (HP:0000848) | 2.32440912 |
| 52 | Supranuclear gaze palsy (HP:0000605) | 2.28828557 |
| 53 | Abnormality of the salivary glands (HP:0010286) | 2.25284538 |
| 54 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.23363551 |
| 55 | Gout (HP:0001997) | 2.20685207 |
| 56 | Urethral obstruction (HP:0000796) | 2.18455285 |
| 57 | Anxiety (HP:0000739) | 2.18262954 |
| 58 | Distal lower limb muscle weakness (HP:0009053) | 2.17877879 |
| 59 | Tetraplegia (HP:0002445) | 2.16823189 |
| 60 | Hyporeflexia of lower limbs (HP:0002600) | 2.16195825 |
| 61 | Pili torti (HP:0003777) | 2.15295236 |
| 62 | Enlarged penis (HP:0000040) | 2.11828418 |
| 63 | Termporal pattern (HP:0011008) | 2.11172190 |
| 64 | Insidious onset (HP:0003587) | 2.11172190 |
| 65 | Overriding aorta (HP:0002623) | 2.11079754 |
| 66 | Hyperglycinuria (HP:0003108) | 2.10250229 |
| 67 | Torticollis (HP:0000473) | 2.09674549 |
| 68 | Mutism (HP:0002300) | 2.08670951 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.07924867 |
| 70 | Hand muscle atrophy (HP:0009130) | 2.07496491 |
| 71 | Impaired smooth pursuit (HP:0007772) | 2.07185890 |
| 72 | Muscle stiffness (HP:0003552) | 2.05880873 |
| 73 | Distal upper limb amyotrophy (HP:0007149) | 2.05314933 |
| 74 | Upper limb amyotrophy (HP:0009129) | 2.05314933 |
| 75 | Hypokalemic alkalosis (HP:0001949) | 2.05152981 |
| 76 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.04817262 |
| 77 | Abnormality of oral frenula (HP:0000190) | 2.03738580 |
| 78 | Progressive cerebellar ataxia (HP:0002073) | 2.03587925 |
| 79 | Broad-based gait (HP:0002136) | 2.02560854 |
| 80 | Cerebral aneurysm (HP:0004944) | 2.01721941 |
| 81 | Cerebral hypomyelination (HP:0006808) | 2.01113360 |
| 82 | Ragged-red muscle fibers (HP:0003200) | 2.00622819 |
| 83 | Hemorrhage of the eye (HP:0011885) | 2.00619932 |
| 84 | Neuronal loss in central nervous system (HP:0002529) | 2.00405019 |
| 85 | Metabolic alkalosis (HP:0200114) | 2.00386887 |
| 86 | Abnormal atrioventricular conduction (HP:0005150) | 1.98683137 |
| 87 | Bradykinesia (HP:0002067) | 1.97634074 |
| 88 | Dysmetria (HP:0001310) | 1.97491756 |
| 89 | Impaired vibratory sensation (HP:0002495) | 1.97184018 |
| 90 | Spastic gait (HP:0002064) | 1.97041771 |
| 91 | Intellectual disability, profound (HP:0002187) | 1.96689572 |
| 92 | Generalized tonic-clonic seizures (HP:0002069) | 1.96237508 |
| 93 | Turricephaly (HP:0000262) | 1.95511466 |
| 94 | Lymphangioma (HP:0100764) | 1.95453312 |
| 95 | Distal lower limb amyotrophy (HP:0008944) | 1.95324763 |
| 96 | Abnormal eating behavior (HP:0100738) | 1.95053039 |
| 97 | Megalencephaly (HP:0001355) | 1.94362077 |
| 98 | Clonus (HP:0002169) | 1.93713971 |
| 99 | Renovascular hypertension (HP:0100817) | 1.93607242 |
| 100 | Ventricular arrhythmia (HP:0004308) | 1.93412587 |
| 101 | Obsessive-compulsive behavior (HP:0000722) | 1.93030075 |
| 102 | Truncal ataxia (HP:0002078) | 1.92939334 |
| 103 | Focal dystonia (HP:0004373) | 1.92394674 |
| 104 | Hyperactive renin-angiotensin system (HP:0000841) | 1.92173362 |
| 105 | Gaze-evoked nystagmus (HP:0000640) | 1.92146102 |
| 106 | Neonatal death (HP:0003811) | 1.91637959 |
| 107 | Neonatal onset (HP:0003623) | 1.91570294 |
| 108 | Easy fatigability (HP:0003388) | 1.91211723 |
| 109 | Absence seizures (HP:0002121) | 1.90732323 |
| 110 | Rhabdomyolysis (HP:0003201) | 1.89179062 |
| 111 | Scanning speech (HP:0002168) | 1.88645590 |
| 112 | Stereotypic behavior (HP:0000733) | 1.88455651 |
| 113 | Hammertoe (HP:0001765) | 1.87211220 |
| 114 | Foot dorsiflexor weakness (HP:0009027) | 1.87153594 |
| 115 | Genetic anticipation (HP:0003743) | 1.86996554 |
| 116 | Hypoglycemic seizures (HP:0002173) | 1.85839303 |
| 117 | Peripheral hypomyelination (HP:0007182) | 1.85191074 |
| 118 | Hypobetalipoproteinemia (HP:0003563) | 1.84868270 |
| 119 | Akinesia (HP:0002304) | 1.84825879 |
| 120 | Visceral angiomatosis (HP:0100761) | 1.83887695 |
| 121 | Abnormality of the foot musculature (HP:0001436) | 1.83524715 |
| 122 | Amyotrophic lateral sclerosis (HP:0007354) | 1.83128896 |
| 123 | Achilles tendon contracture (HP:0001771) | 1.82968997 |
| 124 | Truncus arteriosus (HP:0001660) | 1.82655323 |
| 125 | Abnormality of the Achilles tendon (HP:0005109) | 1.82430125 |
| 126 | Lower limb asymmetry (HP:0100559) | 1.80694092 |
| 127 | Myotonia (HP:0002486) | 1.80546613 |
| 128 | Ketoacidosis (HP:0001993) | 1.80244510 |
| 129 | Flat acetabular roof (HP:0003180) | 1.79374775 |
| 130 | Hypercholesterolemia (HP:0003124) | 1.78942439 |
| 131 | Neurofibrillary tangles (HP:0002185) | 1.78026056 |
| 132 | Alacrima (HP:0000522) | 1.77455880 |
| 133 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.76955294 |
| 134 | Microvesicular hepatic steatosis (HP:0001414) | 1.76703682 |
| 135 | Craniofacial dystonia (HP:0012179) | 1.76272372 |
| 136 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.75281797 |
| 137 | Reticulocytosis (HP:0001923) | 1.75125156 |
| 138 | Fibroma (HP:0010614) | 1.74204055 |
| 139 | Frequent falls (HP:0002359) | 1.73278237 |
| 140 | Lower limb amyotrophy (HP:0007210) | 1.73021048 |
| 141 | Abnormality of saccadic eye movements (HP:0000570) | 1.72524702 |
| 142 | Polygenic inheritance (HP:0010982) | 1.72413983 |
| 143 | Subacute progressive viral hepatitis (HP:0006572) | 1.72349803 |
| 144 | Rapidly progressive (HP:0003678) | 1.72272857 |
| 145 | Abnormality of the astrocytes (HP:0100707) | 1.72205408 |
| 146 | Astrocytoma (HP:0009592) | 1.72205408 |
| 147 | Increased variability in muscle fiber diameter (HP:0003557) | 1.72124718 |
| 148 | Prolonged QT interval (HP:0001657) | 1.71287641 |
| 149 | Limb-girdle muscle atrophy (HP:0003797) | 1.71236763 |
| 150 | Abnormal EKG (HP:0003115) | 1.70513081 |
| 151 | Subaortic stenosis (HP:0001682) | 1.70366050 |
| 152 | Polar cataract (HP:0010696) | 1.69711267 |
| 153 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.69492483 |
| 154 | Hyperparathyroidism (HP:0000843) | 1.68587547 |
| 155 | Broad palm (HP:0001169) | 1.68378813 |
| 156 | Vertebral compression fractures (HP:0002953) | 1.67686456 |
| 157 | Hypoglycemic coma (HP:0001325) | 1.67625533 |
| 158 | Impaired pain sensation (HP:0007328) | 1.67315321 |
| 159 | Abnormality of pain sensation (HP:0010832) | 1.67315321 |
| 160 | Hyperphosphatemia (HP:0002905) | 1.66635237 |
| 161 | Hypokinesia (HP:0002375) | 1.66524656 |
| 162 | Advanced eruption of teeth (HP:0006288) | 1.66392126 |
| 163 | Cholelithiasis (HP:0001081) | 1.65722742 |
| 164 | Seborrheic dermatitis (HP:0001051) | 1.64817952 |
| 165 | Progressive external ophthalmoplegia (HP:0000590) | 1.63183130 |
| 166 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.62640647 |
| 167 | Back pain (HP:0003418) | 1.62160180 |
| 168 | Hemangiomatosis (HP:0007461) | 1.61987230 |
| 169 | Athetosis (HP:0002305) | 1.61750049 |
| 170 | Acanthosis nigricans (HP:0000956) | 1.61015354 |
| 171 | Abnormal gallbladder morphology (HP:0012437) | 1.60304028 |
| 172 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.59847393 |
| 173 | Abnormal cartilage morphology (HP:0002763) | 1.59674338 |
| 174 | Shallow orbits (HP:0000586) | 1.58922274 |
| 175 | Hypercortisolism (HP:0001578) | 1.58823055 |
| 176 | Pterygium (HP:0001059) | 1.58434305 |
| 177 | Increased connective tissue (HP:0009025) | 1.58307752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMG1 | 3.24143707 |
| 2 | MAP3K9 | 3.19879683 |
| 3 | TRIB3 | 3.07353034 |
| 4 | PKN2 | 2.87309829 |
| 5 | EPHA2 | 2.85240631 |
| 6 | NEK1 | 2.75948934 |
| 7 | PRKD3 | 2.61175865 |
| 8 | PRPF4B | 2.60964472 |
| 9 | KSR2 | 2.60417509 |
| 10 | FGFR4 | 2.47411905 |
| 11 | NTRK3 | 2.46829483 |
| 12 | MST1R | 2.41019112 |
| 13 | EPHA4 | 2.38917813 |
| 14 | RIPK1 | 2.35803097 |
| 15 | CAMKK1 | 2.34336554 |
| 16 | LMTK2 | 2.18721471 |
| 17 | PAK6 | 1.99791016 |
| 18 | SCYL2 | 1.99687757 |
| 19 | EEF2K | 1.92572134 |
| 20 | ERN1 | 1.91006968 |
| 21 | DAPK2 | 1.85281929 |
| 22 | MINK1 | 1.81862204 |
| 23 | EIF2AK1 | 1.81695756 |
| 24 | PDK4 | 1.79725863 |
| 25 | PDK3 | 1.79725863 |
| 26 | TAOK1 | 1.76703881 |
| 27 | MAP3K4 | 1.74757391 |
| 28 | MARK1 | 1.73613419 |
| 29 | TTK | 1.63255294 |
| 30 | CDK12 | 1.63236420 |
| 31 | LATS2 | 1.61513701 |
| 32 | TESK1 | 1.59982895 |
| 33 | STK38 | 1.56360350 |
| 34 | TYRO3 | 1.56025125 |
| 35 | MAP3K2 | 1.49655650 |
| 36 | MAP3K7 | 1.45943180 |
| 37 | ALK | 1.45651374 |
| 38 | NTRK2 | 1.41518565 |
| 39 | MAP2K4 | 1.40841410 |
| 40 | PHKG2 | 1.39673199 |
| 41 | PHKG1 | 1.39673199 |
| 42 | SIK3 | 1.38902474 |
| 43 | RET | 1.38143298 |
| 44 | CDK19 | 1.35133549 |
| 45 | NME1 | 1.31335709 |
| 46 | SIK2 | 1.23583870 |
| 47 | PAK4 | 1.22452690 |
| 48 | MET | 1.21148460 |
| 49 | KSR1 | 1.20423929 |
| 50 | NEK6 | 1.19365541 |
| 51 | BUB1 | 1.14748481 |
| 52 | TTN | 1.14254147 |
| 53 | CAMK1 | 1.08831816 |
| 54 | MAPKAPK3 | 1.08444918 |
| 55 | PRKCH | 1.07211823 |
| 56 | PTK2 | 1.07146127 |
| 57 | CDK5 | 1.06948657 |
| 58 | LRRK2 | 1.06606517 |
| 59 | PDK1 | 1.05203432 |
| 60 | STK11 | 1.04728003 |
| 61 | NTRK1 | 1.03797379 |
| 62 | TNIK | 0.97035295 |
| 63 | CAMK1G | 0.96596779 |
| 64 | DMPK | 0.93590702 |
| 65 | PTK6 | 0.92222364 |
| 66 | MAP3K13 | 0.90218614 |
| 67 | DAPK1 | 0.90150044 |
| 68 | PBK | 0.89999426 |
| 69 | RAF1 | 0.88090857 |
| 70 | MST4 | 0.86464207 |
| 71 | CAMKK2 | 0.82138422 |
| 72 | WNK4 | 0.80034721 |
| 73 | PDGFRA | 0.78696193 |
| 74 | WNK1 | 0.76642652 |
| 75 | ARAF | 0.75946825 |
| 76 | NME2 | 0.75580908 |
| 77 | PINK1 | 0.75313492 |
| 78 | PDPK1 | 0.74732800 |
| 79 | VRK2 | 0.74234979 |
| 80 | PAK3 | 0.73817361 |
| 81 | CAMK1D | 0.73738625 |
| 82 | ICK | 0.73633853 |
| 83 | MTOR | 0.73534697 |
| 84 | BRSK1 | 0.73450008 |
| 85 | SGK3 | 0.70953479 |
| 86 | FGFR2 | 0.65580391 |
| 87 | CDK7 | 0.65308281 |
| 88 | BRD4 | 0.64141769 |
| 89 | MAP3K1 | 0.62665033 |
| 90 | MAP3K8 | 0.61043772 |
| 91 | MAP2K7 | 0.60827421 |
| 92 | MAPK11 | 0.59259338 |
| 93 | MAP3K10 | 0.59232595 |
| 94 | FES | 0.57093546 |
| 95 | OXSR1 | 0.57076562 |
| 96 | RPS6KB2 | 0.56799258 |
| 97 | CDK9 | 0.56056416 |
| 98 | FER | 0.56036597 |
| 99 | LIMK1 | 0.55300887 |
| 100 | UHMK1 | 0.54214925 |
| 101 | PDK2 | 0.52502265 |
| 102 | MAP2K6 | 0.52019026 |
| 103 | AKT2 | 0.51397496 |
| 104 | MARK2 | 0.48805545 |
| 105 | RPS6KA3 | 0.48505183 |
| 106 | CDK15 | 0.47728949 |
| 107 | WNK3 | 0.47225768 |
| 108 | PRKCI | 0.47015298 |
| 109 | RIPK4 | 0.47009459 |
| 110 | CHEK1 | 0.46822517 |
| 111 | CDK4 | 0.46716918 |
| 112 | CSNK1G2 | 0.44788323 |
| 113 | CDK11A | 0.44501804 |
| 114 | TNK2 | 0.43245358 |
| 115 | JAK2 | 0.42485199 |
| 116 | MUSK | 0.42049312 |
| 117 | PRKCG | 0.42013257 |
| 118 | BMX | 0.42007228 |
| 119 | SGK1 | 0.41973013 |
| 120 | TSSK6 | 0.41329172 |
| 121 | CAMK2G | 0.41026276 |
| 122 | PTK2B | 0.40718756 |
| 123 | EPHB1 | 0.40423617 |
| 124 | PRKD1 | 0.40376645 |
| 125 | CDK6 | 0.40290801 |
| 126 | CDK18 | 0.40238838 |
| 127 | CDK1 | 0.39366992 |
| 128 | WEE1 | 0.39054947 |
| 129 | MAP2K1 | 0.38566066 |
| 130 | PRKG2 | 0.38290056 |
| 131 | CDK14 | 0.38021660 |
| 132 | FYN | 0.37754076 |
| 133 | SIK1 | 0.37530150 |
| 134 | CAMK4 | 0.37352256 |
| 135 | MAPK10 | 0.37137352 |
| 136 | CDK2 | 0.37031340 |
| 137 | CDC42BPA | 0.36982943 |
| 138 | NEK2 | 0.36763688 |
| 139 | MAP2K3 | 0.36633713 |
| 140 | FGFR3 | 0.36256168 |
| 141 | FLT3 | 0.36219573 |
| 142 | MAPK12 | 0.35992011 |
| 143 | CAMK2B | 0.35985381 |
| 144 | PRKAA1 | 0.34979128 |
| 145 | PAK2 | 0.34138021 |
| 146 | FGFR1 | 0.33910065 |
| 147 | SGK223 | 0.33559088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49058504 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.66041409 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.48203672 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.35973234 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.20826181 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.20348002 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.12887807 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.02834913 |
| 9 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.94978953 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92331677 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.92091250 |
| 12 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.77466279 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.76191678 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.75827787 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70808783 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.70582489 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.70430192 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69789189 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66496785 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.64572039 |
| 21 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.63180174 |
| 22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.62126927 |
| 23 | GABAergic synapse_Homo sapiens_hsa04727 | 1.61399121 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.58250493 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.50840324 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.50265266 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.46819652 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44964157 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44339228 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.42169494 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.38860917 |
| 32 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34404355 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 1.32235357 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.31657645 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.31276437 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.29298491 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23386475 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22234834 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21908082 |
| 40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.18652413 |
| 41 | Glioma_Homo sapiens_hsa05214 | 1.17796411 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.17630971 |
| 43 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15964479 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13692145 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.10947800 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07744461 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07204839 |
| 48 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06291782 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05509622 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.04464096 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03689697 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03395723 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.02959743 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02476696 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02382262 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02055721 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.01717573 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00900940 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.99000360 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97836504 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97714472 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96266635 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 0.95160086 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.94476413 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93738091 |
| 66 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93716607 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91811919 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91271176 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90841155 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.89140789 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88934403 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.88654671 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88254743 |
| 74 | DNA replication_Homo sapiens_hsa03030 | 0.87130862 |
| 75 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86841935 |
| 76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86776604 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86079122 |
| 78 | Long-term depression_Homo sapiens_hsa04730 | 0.85747873 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85512195 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84904331 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84820761 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.84154804 |
| 83 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.84067908 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83825797 |
| 85 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.83605821 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.83590352 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81491889 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81397966 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78620270 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77329121 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75980913 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.75877167 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75242937 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75063897 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74887900 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74555013 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73680023 |
| 98 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73381543 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69771228 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68358251 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.68256196 |
| 102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68161580 |
| 103 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64744198 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63393699 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.62463571 |
| 106 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61926390 |
| 107 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60124052 |
| 108 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.59511522 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59491996 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58629820 |
| 111 | Taste transduction_Homo sapiens_hsa04742 | 0.58050167 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.56591755 |
| 113 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56183246 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55943801 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55482973 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.54978567 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54529234 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51719218 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50706608 |
| 120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50296125 |
| 121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48897084 |
| 122 | Spliceosome_Homo sapiens_hsa03040 | 0.48862243 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47569072 |
| 124 | Cell cycle_Homo sapiens_hsa04110 | 0.45490145 |
| 125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45404988 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44959379 |
| 127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44709116 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.44633851 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43055191 |
| 130 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43041085 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42205776 |
| 132 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41696890 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41544137 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40759468 |
| 135 | Adherens junction_Homo sapiens_hsa04520 | 0.39224846 |
| 136 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35852487 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33867595 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32348984 |
| 139 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31452104 |

